Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cyclic monomer and dimer peptides having integrin antagonist activity

Cyclic monomer and dimer peptides having integrin antagonist activity

US Patent 10301371 · Granted May 28, 2019

Estimated economic value: $5,215,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Lipidated peptide inhibitors of interleukin-23 receptor2025
Conjugated hepcidin mimetics2025
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammator2024
Compositions of peptide inhibitors of Interleukin-23 receptor2024
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflam2024
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflam2024
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammator2023
α4β7 thioether peptide dimer antagonists2023
α4β7 thioether peptide dimer antagonists2023
α4β7 thioether peptide dimer antagonists2023
Conjugated hepcidin mimetics2023
Analogues of hepcidin mimetics with improved in vivo half lives2022